News

UMN Technology Commercialization is collaborating with CTSI’s Office of Discovery and Translation (ODAT) to support the development of novel solutions designed to reduce health disparities.

Claros Technologies, a UMN advanced materials startup, grows functional nanoparticles within plastics, ceramics, or textiles.

The valve-making procedure, which could spare children born with heart defects the need to undergo repeated surgeries, is licensed to UMN startup Vascudyne.

The state is looking to expand Minnesota’s role as a national leader in innovation—and University of Minnesota experts are lending their support.

The new apple, a cross of Honeycrisp and Liberty, is red with a tart flavor and should be available in grocery stores in three to four years.

Tech Comm has been working hard to elevate issues related to equity, diversity, and inclusion (EDI).  As part of this commitment, Tech Comm recently hired a part-time EDI contractor, Michelle Maryns.

Claros Technologies' antiviral textiles provide enhanced protection from COVID-19 when compared with other masks on the market.

Minnesotans' investment in the University made it possible for researchers to quickly develop technologies to address COVID-19 health needs. 

Catamaran Bio, a biotechnology startup developing new cancer treatments, has raised $42 million in venture capital.

Nearly 200 online attendees from across the Twin Cities participated in the 5th Annual Women Innovators Conference, a professional development summit designed to help women innovators connect the dots between their ideas and achieving a positive, significant impact.